Ensuring continuity of care in the use of long-acting buprenorphine (LAB) in the criminal justice pathway

FOR UK HEALTHCARE PROFESSIONALS & OTHER RELEVANT DECISION MAKERS ONLY

Join this meeting to learn from the experience of people who have already met the challenge to offer patients wider choice in opioid dependence treatment with Buvidal^® (prolonged release buprenorphine solution for injection), overcoming the obstacles that were perceived to stand in their way

To view the full agenda and request your place click the link here.